US9169205, 1.1

ID: ALA3985056

PubChem CID: 117871363

Max Phase: Preclinical

Molecular Formula: C24H30N2O3

Molecular Weight: 394.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](C)c1ccc(OC2CCN(c3ccc(OCC4CC4)cc3)C2)cc1

Standard InChI:  InChI=1S/C24H30N2O3/c1-17(25-18(2)27)20-5-9-23(10-6-20)29-24-13-14-26(15-24)21-7-11-22(12-8-21)28-16-19-3-4-19/h5-12,17,19,24H,3-4,13-16H2,1-2H3,(H,25,27)/t17-,24?/m0/s1

Standard InChI Key:  HTXKDWUKUCOXAL-KEJDIYNNSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  1  0  0  0  0  0999 V2000
    2.5958   -2.7022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5978   -1.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8990   -0.7543    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1978   -1.5065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2382   -0.9086    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1958   -2.7065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6003    1.4977    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8990    0.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2526    1.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2524    0.2436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4979   -1.0529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0317   -0.7359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.1035   -2.4260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5736   -2.6979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.0739   -4.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.0995   -5.2524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5972   -6.6683    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.6206   -7.8079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1183   -9.2238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.8141  -10.6124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.2282  -10.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6247   -4.9786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1243   -3.5646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  2  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 23  1  0
 20 26  1  0
 26 27  2  0
 27 17  1  0
 10 28  1  0
 28 29  2  0
 29  7  1  0
M  END

Associated Targets(Human)

ACACB Tchem Acetyl-CoA carboxylase 2 (3474 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.52Molecular Weight (Monoisotopic): 394.2256AlogP: 4.33#Rotatable Bonds: 8
Polar Surface Area: 50.80Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.29CX LogP: 3.66CX LogD: 3.66
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.72Np Likeness Score: -1.03

References

1.  (2015)  Pyrrolidine derivatives, pharmaceutical compositions and uses thereof, 

Source

Source(1):